van't Veer Archives - Agendia Inc.

Tamoxifen Therapy Benefit for Patients with 70-gene Signature High and Low Risk
Gallery
Tamoxifen Therapy Benefit for Patients with 70-gene Signature High and Low Risk

Breast Cancer Research Treatment, Clinical Validation, Evidence, MammaPrint, van't Veer

Tamoxifen Therapy Benefit for Patients with 70-gene Signature High and Low Risk

PUBLICATION: Breast Cancer Res Treat (2017) 166: 593. https://doi.org/10.1007/s10549-017-4428-9. AUTHORS: Read More

kevin2020-06-15T18:02:13-07:00November 1st, 2017|Breast Cancer Research Treatment, Clinical Validation, Evidence, MammaPrint, van't Veer|

Gene Expression Profiling of Breast Cancer: A New Tumor Marker
Gene Expression Profiling of Breast Cancer: A New Tumor Marker

Clinical Validation, Evidence, Journal of Clinical Oncology, MammaPrint, van't Veer

Gene Expression Profiling of Breast Cancer: A New Tumor Marker

PUBLICATION: Journal of Clinical Oncology March 10, 2005 23:8, 1631-1635 AUTHORS: Laura Read More

kevin2005-03-10T16:31:04-08:00March 10th, 2005|Clinical Validation, Evidence, Journal of Clinical Oncology, MammaPrint, van't Veer|

Gene Expression Profiling Predicts Clinical Outcome of Breast Cancer
Gene Expression Profiling Predicts Clinical Outcome of Breast Cancer

Evidence, MammaPrint, Nature, Test Development, van't Veer

Gene Expression Profiling Predicts Clinical Outcome of Breast Cancer

PUBLICATION: Nature. 2002 Jan 31;415(6871):530-6. AUTHORS: van 't Veer L.J., Dai H., Read More

kevin2002-01-31T22:40:05-08:00January 31st, 2002|Evidence, MammaPrint, Nature, Test Development, van't Veer|

agendia_logo_stacked_white_po

Quick Links

Our Tests
Resources
Landmark Trials
Order A Test
For Patients

Legal

Privacy Policy
Legal & Compliance
Terms & Conditions
Licenses & Accreditations
Code of Conduct

Contact

For the US, Puerto Rico, Canada
and South America
Agendia Inc. USA, 22 Morgan, Irvine, CA 92618
(888) 321-2732
customercare@agendia.com

For outside the Americas
Agendia NV, Radarweg 60, 1043 NT Amsterdam, The Netherlands
+31 (0)20 462 1510
customerservice@agendia.com

© 2022 Agendia. All rights reserved. MammaPrint and Blueprint are registered trademarks of Agendia, Inc.